What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
Pathology, Cancer research, Carcinoma, Cancer and Tissue microarray are his primary areas of study.
His biological study spans a wide range of topics, including Internal medicine and Metastasis.
His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Mammary gland.
His research in Cancer research intersects with topics in Tumor suppressor gene, Oncogene, Clear cell renal cell carcinoma and PTEN.
His study explores the link between Carcinoma and topics such as Radiology that cross with problems in Surgery.
His Tissue microarray research is multidisciplinary, relying on both Bladder cancer, Fluorescence in situ hybridization and Proliferation index.
His most cited work include:
- Endothelial cell infection and endotheliitis in COVID-19. (2154 citations)
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas (1328 citations)
- Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. (1213 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Pathology, Cancer research, Cancer, Internal medicine and Immunohistochemistry.
His Pathology study frequently draws connections between related disciplines such as Metastasis.
His research integrates issues of Carcinogenesis, Gene, Clear cell renal cell carcinoma, Fluorescence in situ hybridization and PTEN in his study of Cancer research.
His Fluorescence in situ hybridization research includes themes of Gene duplication, Molecular biology and Bladder cancer.
His Internal medicine research includes elements of Endocrinology and Oncology.
His Immunohistochemistry study frequently draws parallels with other fields, such as Antigen.
He most often published in these fields:
- Pathology (37.19%)
- Cancer research (29.06%)
- Cancer (19.97%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (29.06%)
- Cancer (19.97%)
- Pathology (37.19%)
In recent papers he was focusing on the following fields of study:
Holger Moch spends much of his time researching Cancer research, Cancer, Pathology, Internal medicine and Renal cell carcinoma.
His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Gene, Clear cell renal cell carcinoma, Metastasis and Breast cancer.
His Cancer study combines topics in areas such as Cell, Molecular pathology and Clear cell.
His study in Immunohistochemistry and Autopsy is carried out as part of his Pathology studies.
As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Oncology and frequently concerns with Epidemiology, Chemotherapy and Disease.
His Renal cell carcinoma study combines topics from a wide range of disciplines, such as Carcinoma and Kidney.
Between 2017 and 2021, his most popular works were:
- Endothelial cell infection and endotheliitis in COVID-19. (2154 citations)
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. (264 citations)
- The single-cell pathology landscape of breast cancer (130 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Cancer research, Cancer, Pathology, Internal medicine and Clear cell renal cell carcinoma.
Holger Moch interconnects Mutation, Ceritinib and Chromosomal translocation in the investigation of issues within Cancer research.
His study in Cancer is interdisciplinary in nature, drawing from both Cell, Carcinoma and Stem cell.
His research on Pathology often connects related areas such as Consensus conference.
Holger Moch works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Epidemiology, Cohort, Cancer of unknown primary and Confounding, as a part of the same area of interest.
His Clear cell renal cell carcinoma research integrates issues from Cell culture, Regulation of gene expression, Gene mutation and Clear cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
